Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Nunn

Showing results (31-40 of 102) with videos related to

Pageof 11
Sort By:
Contemporary Clinical Trials|May 27, 2015
Safety of discontinuing cotrimoxazole prophylaxis among HIV infected adults on anti-retroviral therapy in Uganda (COSTOP trial): DesignZacchaeus Anywaine, Andrew Abaasa, Jonathan Levin, et al.
Reproductive Health|March 13, 2017
Uptake of hormonal contraceptives and correlates of uptake in a phase III clinical trial in rural South Western UgandaAndrew Abaasa, Mitzy Gafos, Zacchaeus Anywaine, et al.
Spinal Cord|May 18, 2021
Employment outcomes following spinal cord injury: a population-based cross-sectional study in AustraliaSamantha J Borg, Timothy Geraghty, Mohit Arora, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 27, 2006
Determinants of survival without antiretroviral therapy after infancy in HIV-1-infected Zambian children in the CHAP TrialA Sarah Walker, Veronica Mulenga, Frederick Sinyinza, et al.
Malaria Journal|July 16, 2016
Longitudinal effect of CD4 by cotrimoxazole use on malaria incidence among HIV-infected Ugandan adults on antiretroviral therapy: a randomized controlled studyRonnie Kasirye, Heiner Grosskurth, Paula Munderi, et al.
Lancet (London, England)|October 18, 2002
Mycobacterium vaccae (SRL172) immunotherapy as an adjunct to standard antituberculosis treatment in HIV-infected adults with pulmonary tuberculosis: a randomised placebo-controlled trialAlwyn Mwinga, Andrew Nunn, Bagrey Ngwira, et al.
Journal of Neuroengineering and Rehabilitation|June 21, 2017
Results of the first interim analysis of the RAPPER II trial in patients with spinal cord injury: ambulation and functional exercise programs in the REX powered walking aidNick Birch, Jon Graham, Tom Priestley, et al.
Thorax|November 1, 2012
Continuous positive airway pressure improves sleepiness but not calculated vascular risk in patients with minimally symptomatic obstructive sleep apnoea: the MOSAIC randomised controlled trialSonya Elizabeth Craig, Malcolm Kohler, Debby Nicoll, et al.
AIDS (London, England)|January 26, 2017
Effect of antiretroviral therapy on malaria incidence in HIV-infected Ugandan adultsRonnie P Kasirye, Heiner Grosskurth, Paula Munderi, et al.
AIDS (London, England)|November 13, 2015
Incidence of malaria by cotrimoxazole use in HIV-infected Ugandan adults on antiretroviral therapy: a randomised, placebo-controlled studyRonnie P Kasirye, Kathy Baisley, Paula Munderi, et al.
Pageof 11

Showing results (31-40 of 102) with videos related to

Sort By:
Pageof 11
Contemporary Clinical Trials|May 27, 2015
Safety of discontinuing cotrimoxazole prophylaxis among HIV infected adults on anti-retroviral therapy in Uganda (COSTOP trial): DesignZacchaeus Anywaine, Andrew Abaasa, Jonathan Levin, et al.
Reproductive Health|March 13, 2017
Uptake of hormonal contraceptives and correlates of uptake in a phase III clinical trial in rural South Western UgandaAndrew Abaasa, Mitzy Gafos, Zacchaeus Anywaine, et al.
Spinal Cord|May 18, 2021
Employment outcomes following spinal cord injury: a population-based cross-sectional study in AustraliaSamantha J Borg, Timothy Geraghty, Mohit Arora, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 27, 2006
Determinants of survival without antiretroviral therapy after infancy in HIV-1-infected Zambian children in the CHAP TrialA Sarah Walker, Veronica Mulenga, Frederick Sinyinza, et al.
Malaria Journal|July 16, 2016
Longitudinal effect of CD4 by cotrimoxazole use on malaria incidence among HIV-infected Ugandan adults on antiretroviral therapy: a randomized controlled studyRonnie Kasirye, Heiner Grosskurth, Paula Munderi, et al.
Lancet (London, England)|October 18, 2002
Mycobacterium vaccae (SRL172) immunotherapy as an adjunct to standard antituberculosis treatment in HIV-infected adults with pulmonary tuberculosis: a randomised placebo-controlled trialAlwyn Mwinga, Andrew Nunn, Bagrey Ngwira, et al.
Journal of Neuroengineering and Rehabilitation|June 21, 2017
Results of the first interim analysis of the RAPPER II trial in patients with spinal cord injury: ambulation and functional exercise programs in the REX powered walking aidNick Birch, Jon Graham, Tom Priestley, et al.
Thorax|November 1, 2012
Continuous positive airway pressure improves sleepiness but not calculated vascular risk in patients with minimally symptomatic obstructive sleep apnoea: the MOSAIC randomised controlled trialSonya Elizabeth Craig, Malcolm Kohler, Debby Nicoll, et al.
AIDS (London, England)|January 26, 2017
Effect of antiretroviral therapy on malaria incidence in HIV-infected Ugandan adultsRonnie P Kasirye, Heiner Grosskurth, Paula Munderi, et al.
AIDS (London, England)|November 13, 2015
Incidence of malaria by cotrimoxazole use in HIV-infected Ugandan adults on antiretroviral therapy: a randomised, placebo-controlled studyRonnie P Kasirye, Kathy Baisley, Paula Munderi, et al.
Pageof 11